SIMILAR PATTERNS OF AMINO ACIDS FOR 4RVJ_D_478D101_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E 215
GLY E 217
VAL E 222
GLY E  76
ILE E 300
None
0.76A 4rvjD-1cziE:
6.6
4rvjD-1cziE:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.58A 4rvjD-1cziE:
6.6
4rvjD-1cziE:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1deu PROCATHEPSIN X

(Homo sapiens)
PF00112
(Peptidase_C1)
6 LEU A  57
GLY A  87
ALA A  83
ASP A  81
GLY A 130
ILE A 241
None
1.25A 4rvjD-1deuA:
undetectable
4rvjD-1deuA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ef7 CATHEPSIN X

(Homo sapiens)
PF00112
(Peptidase_C1)
6 LEU A  57
GLY A  87
ALA A  83
ASP A  81
GLY A 130
ILE A 241
None
1.28A 4rvjD-1ef7A:
undetectable
4rvjD-1ef7A:
19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ek6 UDP-GALACTOSE
4-EPIMERASE


(Homo sapiens)
PF16363
(GDP_Man_Dehyd)
5 LEU A  68
GLY A  90
ALA A  89
ILE A 164
ILE A  67
None
NAI  A 400 (-4.1A)
NAI  A 400 (-3.7A)
None
NAI  A 400 (-3.8A)
0.79A 4rvjD-1ek6A:
undetectable
4rvjD-1ek6A:
14.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
A79  A 800 (-3.6A)
0.85A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-4.1A)
A79  A 800 (-3.8A)
0.95A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.23A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.23A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
0.44A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-3.8A)
0.46A 4rvjD-1hvcA:
13.8
4rvjD-1hvcA:
43.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ig8 HEXOKINASE PII

(Saccharomyces
cerevisiae)
PF00349
(Hexokinase_1)
PF03727
(Hexokinase_2)
5 LEU A  41
GLY A 399
ALA A 401
ILE A 453
ILE A 438
None
0.92A 4rvjD-1ig8A:
undetectable
4rvjD-1ig8A:
11.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kae HISTIDINOL
DEHYDROGENASE


(Escherichia
coli)
PF00815
(Histidinol_dh)
5 GLY A 227
ALA A 228
ASP A 204
GLY A 196
ILE A 206
None
0.91A 4rvjD-1kaeA:
undetectable
4rvjD-1kaeA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kng THIOL:DISULFIDE
INTERCHANGE PROTEIN
CYCY


(Bradyrhizobium
japonicum)
PF08534
(Redoxin)
5 LEU A  57
ASP A 142
GLY A 145
GLY A 152
ILE A 116
None
0.92A 4rvjD-1kngA:
undetectable
4rvjD-1kngA:
25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.78A 4rvjD-1l5jA:
undetectable
4rvjD-1l5jA:
8.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 LEU A  30
ASP A  32
GLY A  34
ASP A  37
ILE A 120
None
0.80A 4rvjD-1mppA:
7.2
4rvjD-1mppA:
13.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
0.51A 4rvjD-1q9pA:
10.5
4rvjD-1q9pA:
84.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.23A 4rvjD-1sivA:
18.3
4rvjD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
0.50A 4rvjD-1sivA:
18.3
4rvjD-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1suu DNA GYRASE SUBUNIT A

(Borreliella
burgdorferi)
PF03989
(DNA_gyraseA_C)
6 GLY A 780
ALA A 779
VAL A 805
GLY A 722
ILE A 792
ILE A 765
None
1.48A 4rvjD-1suuA:
undetectable
4rvjD-1suuA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.92A 4rvjD-1v5fA:
undetectable
4rvjD-1v5fA:
10.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.69A 4rvjD-2bc0A:
undetectable
4rvjD-2bc0A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cvj THIOREDOXIN
REDUCTASE RELATED
PROTEIN


(Thermus
thermophilus)
PF00890
(FAD_binding_2)
PF07992
(Pyr_redox_2)
5 LEU A 170
GLY A  24
ALA A  23
ASP A 177
VAL A 164
None
0.94A 4rvjD-2cvjA:
undetectable
4rvjD-2cvjA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dws COPPER-CONTAINING
NITRITE REDUCTASE


(Rhodobacter
sphaeroides)
PF00394
(Cu-oxidase)
PF07732
(Cu-oxidase_3)
5 LEU A  90
GLY A 254
ALA A 255
GLY A 347
ILE A 250
None
0.83A 4rvjD-2dwsA:
undetectable
4rvjD-2dwsA:
14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e4u METABOTROPIC
GLUTAMATE RECEPTOR 3


(Rattus
norvegicus)
PF01094
(ANF_receptor)
PF07562
(NCD3G)
5 LEU A  86
GLY A  92
ASP A  77
ILE A 146
ILE A  79
None
0.87A 4rvjD-2e4uA:
undetectable
4rvjD-2e4uA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
BTX  A 501 (-3.3A)
None
None
None
None
0.81A 4rvjD-2ewnA:
undetectable
4rvjD-2ewnA:
20.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
VAL A  32
GLY A  54
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.83A 4rvjD-2fmbA:
15.2
4rvjD-2fmbA:
33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
0.44A 4rvjD-2fmbA:
15.2
4rvjD-2fmbA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2guh PUTATIVE TETR-FAMILY
TRANSCRIPTIONAL
REGULATOR


(Rhodococcus
jostii)
PF00440
(TetR_N)
6 LEU A  53
GLY A  48
ALA A  47
ASP A  24
VAL A  23
ILE A  22
None
1.43A 4rvjD-2guhA:
undetectable
4rvjD-2guhA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oer PROBABLE
TRANSCRIPTIONAL
REGULATOR


(Pseudomonas
aeruginosa)
PF00440
(TetR_N)
5 LEU A  23
GLY A  53
ALA A  52
ILE A  56
ILE A  27
None
0.82A 4rvjD-2oerA:
undetectable
4rvjD-2oerA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2omj RHO GUANINE
NUCLEOTIDE EXCHANGE
FACTOR 12


(Homo sapiens)
PF00595
(PDZ)
5 LEU A  80
GLY A  45
ALA A  44
GLY A  39
ILE A  13
None
0.84A 4rvjD-2omjA:
undetectable
4rvjD-2omjA:
27.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.94A 4rvjD-2p3eA:
undetectable
4rvjD-2p3eA:
10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ph3 3-OXOACYL-[ACYL
CARRIER PROTEIN]
REDUCTASE


(Thermus
thermophilus)
PF13561
(adh_short_C2)
5 LEU A  28
GLY A  14
ALA A   9
VAL A  56
ILE A  30
None
0.86A 4rvjD-2ph3A:
undetectable
4rvjD-2ph3A:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjc DIADENOSINE
TETRAPHOSPHATASE,
PUTATIVE


(Trypanosoma
brucei)
PF00149
(Metallophos)
5 LEU A  14
GLY A  19
VAL A 137
ILE A  22
ILE A 132
None
0.83A 4rvjD-2qjcA:
undetectable
4rvjD-2qjcA:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
5 LEU A 283
GLY A  63
ALA A  62
GLY A  57
ILE A 280
None
0.72A 4rvjD-2ri6A:
undetectable
4rvjD-2ri6A:
16.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.36A 4rvjD-2rkfA:
20.1
4rvjD-2rkfA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.53A 4rvjD-2rkfA:
20.1
4rvjD-2rkfA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ILE A 108
None
0.44A 4rvjD-2rspA:
13.0
4rvjD-2rspA:
29.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.79A 4rvjD-2wskA:
undetectable
4rvjD-2wskA:
9.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yfq NAD-SPECIFIC
GLUTAMATE
DEHYDROGENASE


(Peptoniphilus
asaccharolyticus)
PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N)
6 LEU A 317
ALA A 213
ASP A 212
GLY A 236
ILE A 231
ILE A 208
None
1.28A 4rvjD-2yfqA:
undetectable
4rvjD-2yfqA:
15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 LEU A 148
GLY A 191
ALA A 213
GLY A 256
ILE A 189
None
0.87A 4rvjD-3gf7A:
undetectable
4rvjD-3gf7A:
11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i4o TRANSLATION
INITIATION FACTOR
IF-1


(Mycobacterium
tuberculosis)
PF01176
(eIF-1a)
5 LEU A  27
GLY A  66
ALA A  35
VAL A  14
ILE A  25
None
0.91A 4rvjD-3i4oA:
undetectable
4rvjD-3i4oA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kl7 PUTATIVE
METAL-DEPENDENT
HYDROLASE


(Parabacteroides
distasonis)
PF13483
(Lactamase_B_3)
5 LEU A 156
GLY A 153
ASP A 120
ILE A  77
ILE A 130
None
0.83A 4rvjD-3kl7A:
undetectable
4rvjD-3kl7A:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
6 LEU A 251
GLY A 256
ALA A 255
ASP A 246
ILE A 319
ILE A 248
None
1.10A 4rvjD-3mdoA:
undetectable
4rvjD-3mdoA:
12.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
None
0.81A 4rvjD-3mwsA:
19.3
4rvjD-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.28A 4rvjD-3mwsA:
19.3
4rvjD-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
0.49A 4rvjD-3mwsA:
19.3
4rvjD-3mwsA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
0.47A 4rvjD-3mwsA:
19.3
4rvjD-3mwsA:
70.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pdx TYROSINE
AMINOTRANSFERASE


(Mus musculus)
PF00155
(Aminotran_1_2)
5 LEU A 331
GLY A 325
ALA A 326
VAL A  93
ILE A 330
None
0.92A 4rvjD-3pdxA:
undetectable
4rvjD-3pdxA:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s52 PUTATIVE
FUMARYLACETOACETATE
HYDROLASE FAMILY
PROTEIN


(Yersinia pestis)
PF01557
(FAA_hydrolase)
5 GLY A  97
ALA A  74
VAL A  19
ILE A  54
ILE A 186
None
0.92A 4rvjD-3s52A:
undetectable
4rvjD-3s52A:
20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.52A 4rvjD-3slzA:
11.9
4rvjD-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sm9 METABOTROPIC
GLUTAMATE RECEPTOR 3


(Homo sapiens)
PF01094
(ANF_receptor)
5 LEU A  61
GLY A  67
ASP A  52
ILE A 121
ILE A  54
None
0.92A 4rvjD-3sm9A:
undetectable
4rvjD-3sm9A:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t05 PYRUVATE KINASE

(Staphylococcus
aureus)
PF00224
(PK)
PF00391
(PEP-utilizers)
PF02887
(PK_C)
5 GLY A 575
VAL A 487
GLY A 483
ILE A 482
ILE A 570
None
0.93A 4rvjD-3t05A:
undetectable
4rvjD-3t05A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t2y SULFIDE-QUINONE
REDUCTASE, PUTATIVE


(Acidithiobacillus
ferrooxidans)
PF07992
(Pyr_redox_2)
5 LEU A   7
GLY A 106
ALA A 303
GLY A 281
ILE A 103
FAD  A 500 (-4.7A)
FAD  A 500 (-3.1A)
None
None
None
0.68A 4rvjD-3t2yA:
undetectable
4rvjD-3t2yA:
13.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
1.37A 4rvjD-3t3cA:
18.4
4rvjD-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.40A 4rvjD-3t3cA:
18.4
4rvjD-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
1.26A 4rvjD-3ttpA:
19.4
4rvjD-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.7A)
0.55A 4rvjD-3ttpA:
19.4
4rvjD-3ttpA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
1.28A 4rvjD-3u7sA:
19.8
4rvjD-3u7sA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.29A 4rvjD-3u7sA:
19.8
4rvjD-3u7sA:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ufc PUTATIVE
UNCHARACTERIZED
PROTEIN


(Pyrococcus
furiosus)
PF01881
(Cas_Cas6)
5 LEU X 193
GLY X 231
GLY X 225
ILE X 132
ILE X 200
None
0.93A 4rvjD-3ufcX:
undetectable
4rvjD-3ufcX:
16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3umm PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
SYNTHASE


(Salmonella
enterica)
PF02769
(AIRS_C)
PF13507
(GATase_5)
6 LEU A 498
GLY A 433
ALA A 580
VAL A 516
GLY A 578
ILE A 430
None
1.34A 4rvjD-3ummA:
undetectable
4rvjD-3ummA:
5.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uzu RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A


(Burkholderia
pseudomallei)
PF00398
(RrnaAD)
5 LEU A  88
GLY A  48
VAL A  56
GLY A 116
ILE A  45
None
0.81A 4rvjD-3uzuA:
undetectable
4rvjD-3uzuA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g6c BETA-HEXOSAMINIDASE
1


(Burkholderia
cenocepacia)
PF00933
(Glyco_hydro_3)
5 ASP A 128
GLY A 174
VAL A 136
ILE A 215
ILE A 137
None
0.82A 4rvjD-4g6cA:
undetectable
4rvjD-4g6cA:
15.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4inj LMO1638 PROTEIN

(Listeria
monocytogenes)
PF02016
(Peptidase_S66)
5 LEU A 162
ALA A 309
GLY A 306
ILE A 305
ILE A 321
None
0.84A 4rvjD-4injA:
undetectable
4rvjD-4injA:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ky0 PROTON/GLUTAMATE
SYMPORTER, SDF
FAMILY


(Thermococcus
kodakarensis)
PF00375
(SDF)
5 GLY A 210
ALA A 213
VAL A  41
GLY A  25
ILE A  45
None
0.92A 4rvjD-4ky0A:
undetectable
4rvjD-4ky0A:
14.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.80A 4rvjD-4njvA:
20.0
4rvjD-4njvA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.27A 4rvjD-4njvA:
20.0
4rvjD-4njvA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.3A)
0.45A 4rvjD-4njvA:
20.0
4rvjD-4njvA:
98.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
0.40A 4rvjD-4njvA:
20.0
4rvjD-4njvA:
98.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nnm TAX1-BINDING PROTEIN
3


(Homo sapiens)
PF00595
(PDZ)
5 LEU A 108
GLY A  71
ALA A  70
GLY A  65
ILE A  19
None
0.93A 4rvjD-4nnmA:
undetectable
4rvjD-4nnmA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nzr PROTEIN M TD

(Mycoplasma
genitalium)
no annotation 6 LEU M 278
GLY M 270
ALA M 248
ASP M 250
ILE M 267
ILE M 251
None
None
None
None
GOL  M 501 ( 4.3A)
None
1.27A 4rvjD-4nzrM:
undetectable
4rvjD-4nzrM:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oy7 PUTATIVE SECRETED
CELLULOSE BINDING
PROTEIN


(Streptomyces
coelicolor)
PF03067
(LPMO_10)
5 LEU A 194
GLY A 131
ALA A 132
GLY A 229
ILE A 134
None
0.92A 4rvjD-4oy7A:
undetectable
4rvjD-4oy7A:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pyr PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC TRANSPORTER


(Chromobacterium
violaceum)
PF04348
(LppC)
5 LEU A 166
VAL A  88
GLY A 107
ILE A 337
ILE A 146
None
0.68A 4rvjD-4pyrA:
undetectable
4rvjD-4pyrA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qi6 CELLOBIOSE
DEHYDROGENASE


(Crassicarpon
hotsonii)
PF00732
(GMC_oxred_N)
PF00734
(CBM_1)
PF05199
(GMC_oxred_C)
PF16010
(CDH-cyt)
5 LEU A 489
GLY A 481
ALA A 480
ILE A 477
ILE A 488
None
FAD  A 902 (-3.6A)
FAD  A 902 (-3.9A)
None
None
0.92A 4rvjD-4qi6A:
undetectable
4rvjD-4qi6A:
8.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ql6 CARBOXY-TERMINAL
PROCESSING PROTEASE


(Chlamydia
trachomatis)
PF00595
(PDZ)
PF03572
(Peptidase_S41)
5 LEU A 360
GLY A 400
VAL A 449
ILE A 459
ILE A 395
None
0.90A 4rvjD-4ql6A:
undetectable
4rvjD-4ql6A:
10.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B


(Homo sapiens)
PF10294
(Methyltransf_16)
5 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.75A 4rvjD-4qpnA:
undetectable
4rvjD-4qpnA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xib E3 UBIQUITIN-PROTEIN
LIGASE MIB1


(Homo sapiens)
PF00569
(ZZ)
PF06701
(MIB_HERC2)
6 LEU A 215
GLY A 154
ALA A 155
ASP A 220
GLY A 223
ILE A 151
None
1.41A 4rvjD-4xibA:
undetectable
4rvjD-4xibA:
14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xll DJ-1 FAMILY PROTEIN

(Toxoplasma
gondii)
PF01965
(DJ-1_PfpI)
5 LEU A 168
GLY A  29
ALA A  28
ILE A  22
ILE A 165
None
0.85A 4rvjD-4xllA:
undetectable
4rvjD-4xllA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xr9 CALS8

(Micromonospora
echinospora)
PF00984
(UDPG_MGDP_dh)
PF03720
(UDPG_MGDP_dh_C)
PF03721
(UDPG_MGDP_dh_N)
5 ASP A 248
VAL A 249
GLY A 452
ILE A 451
ILE A 250
None
0.90A 4rvjD-4xr9A:
undetectable
4rvjD-4xr9A:
14.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.67A 4rvjD-4ydfA:
13.4
4rvjD-4ydfA:
33.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
None
0.86A 4rvjD-5b18A:
18.4
4rvjD-5b18A:
79.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cni METABOTROPIC
GLUTAMATE RECEPTOR 2


(Homo sapiens)
PF01094
(ANF_receptor)
5 LEU A  79
GLY A  85
ASP A  70
ILE A 140
ILE A  72
None
0.92A 4rvjD-5cniA:
undetectable
4rvjD-5cniA:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw2 PUTATIVE EPOXIDE
HYDROLASE EPHA


(Mycolicibacterium
thermoresistibile)
no annotation 5 LEU C 315
GLY C  53
ALA C  52
ILE C  46
ILE C 312
None
0.77A 4rvjD-5cw2C:
undetectable
4rvjD-5cw2C:
15.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw5 BRCA1/BRCA2-CONTAINI
NG COMPLEX SUBUNIT 3


(Camponotus
floridanus)
PF01398
(JAB)
5 LEU A  79
VAL A  89
GLY A  33
ILE A  51
ILE A  36
None
0.92A 4rvjD-5cw5A:
undetectable
4rvjD-5cw5A:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ej1 PUTATIVE CELLULOSE
SYNTHASE


(Rhodobacter
sphaeroides)
PF00535
(Glycos_transf_2)
PF03552
(Cellulose_synt)
PF07238
(PilZ)
5 LEU A 688
GLY A 614
VAL A 681
GLY A 655
ILE A 637
None
C2E  A 919 (-3.4A)
None
None
None
0.76A 4rvjD-5ej1A:
undetectable
4rvjD-5ej1A:
9.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ema SORTING NEXIN-27

(Rattus
norvegicus)
PF00595
(PDZ)
5 LEU A 130
GLY A  94
ALA A  93
GLY A  88
ILE A  46
None
0.90A 4rvjD-5emaA:
undetectable
4rvjD-5emaA:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGR
MOLYBDENUM-BINDING
SU SUBUNIT


(Escherichia
coli)
PF00941
(FAD_binding_5)
PF03450
(CO_deh_flav_C)
5 LEU B 172
ALA B  94
ASP B 164
VAL B 167
ILE B 227
None
None
FAD  B 321 (-3.9A)
None
None
0.92A 4rvjD-5g5gB:
undetectable
4rvjD-5g5gB:
15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT


(Escherichia
coli)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 GLY A 211
ALA A 212
ASP A 154
GLY A 159
ILE A 216
None
None
None
FES  A 230 (-4.2A)
None
0.88A 4rvjD-5g5gA:
undetectable
4rvjD-5g5gA:
24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ija HYDROGENASE-SPECIFIC
MATURATION
ENDOPEPTIDASE


(Thermococcus
kodakarensis)
PF01750
(HycI)
6 GLY A  17
ALA A  18
ASP A  57
GLY A  23
ILE A  25
ILE A 117
None
1.49A 4rvjD-5ijaA:
undetectable
4rvjD-5ijaA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5it1 PUTATIVE CYTOCHROME
P450


(Streptomyces
peucetius)
PF00067
(p450)
5 ALA A 238
VAL A 150
GLY A 350
ILE A 349
ILE A 151
HEM  A 401 (-3.1A)
None
HEM  A 401 ( 3.7A)
HEM  A 401 (-4.4A)
None
0.91A 4rvjD-5it1A:
undetectable
4rvjD-5it1A:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jxk ASP/GLU-SPECIFIC
DIPEPTIDYL-PEPTIDASE


(Porphyromonas
endodontalis)
PF10459
(Peptidase_S46)
5 GLY A 583
ALA A 594
VAL A 263
ILE A 689
ILE A 581
None
0.91A 4rvjD-5jxkA:
undetectable
4rvjD-5jxkA:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kzn METABOTROPIC
GLUTAMATE RECEPTOR 2


(Homo sapiens)
PF01094
(ANF_receptor)
PF07562
(NCD3G)
5 LEU A  79
GLY A  85
ASP A  70
ILE A 140
ILE A  72
None
0.89A 4rvjD-5kznA:
undetectable
4rvjD-5kznA:
11.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.28A 4rvjD-5t2zA:
19.7
4rvjD-5t2zA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
0.51A 4rvjD-5t2zA:
19.7
4rvjD-5t2zA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tf0 GLYCOSYL HYDROLASE
FAMILY 3 N-TERMINAL
DOMAIN PROTEIN


(Bacteroides
intestinalis)
PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like)
5 GLY A 452
VAL A 461
GLY A 589
ILE A 588
ILE A 463
None
0.88A 4rvjD-5tf0A:
undetectable
4rvjD-5tf0A:
8.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5z2e DIHYDRODIPICOLINATE
REDUCTASE


(Paenisporosarcina
sp. TG-14)
no annotation 6 GLY A 259
ALA A 124
VAL A  96
GLY A 242
ILE A 129
ILE A 122
None
1.46A 4rvjD-5z2eA:
undetectable
4rvjD-5z2eA:
21.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 LEU A  28
ASP A  30
GLY A  32
ALA A  33
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.4A)
0.28A 4rvjD-6fivA:
15.8
4rvjD-6fivA:
31.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gbc MOLYBDOPTERIN
BIOSYNTHESIS PROTEIN
CNX1


(Arabidopsis
thaliana)
no annotation 5 GLY A 181
ALA A 180
GLY A 175
ILE A 174
ILE A  52
None
0.92A 4rvjD-6gbcA:
undetectable
4rvjD-6gbcA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.77A 4rvjD-6upjA:
17.6
4rvjD-6upjA:
47.47